ICU Medical Operating Profit Margin History

ICUI Stock  USD 129.40  -0.53  -0.41%   
You can find Operating Profit Margin on ICU Medical's' income statement. Operating Profit Margin is currently 0.05, down 5.17% year over year from a comparable level. Its Operating Profit Margin is retreating over several periods.

Latest ICU Medical's Operating Profit Margin Growth Pattern

ICU Medical's reported Operating Profit Margin across 15 annual data points is presented below. Historical consistency or divergence from the mean can inform forward-looking analysis. A widening range in ICU Medical's Operating Profit Margin can signal increasing variability in the underlying drivers. Whether the current level is sustainable depends on the drivers behind the retreating trend. Quarter-over-quarter noise in ICU Medical's Operating Profit Margin is smoothed by the longer-term trend direction.
Operating Profit Margin10 Years Trend
Slightly volatile
All content is derived from available financial data inputs.
   Operating Profit Margin   
       Timeline  

Operating Profit Margin Trend Statistics

Arithmetic Mean 0.12
Geometric Mean 0.07
Coefficient Of Variation 113.18
Mean Deviation 0.1
Median 0.08
Standard Deviation 0.13
Sample Variance 0.02
Range0.5521
R-Value-0.74
Mean Square Error 0.01
R-Squared 0.54
Significance 0.0007
Slope-0.02
Total Sum of Squares 0.29

ICU Medical Operating Profit Margin History

2026 0.0456
2025 0.048
2024 0.018
2023 0.0101
2022 -0.0188
2021 0.0936
2020 0.0772
2019 0.0848
2018 0.0154
2017 -0.0117
2015 0.2
2014 0.13
2013 0.17
2012 0.19
2011 0.22

Related Accounts

Methodology, Assumptions & Data Sources

ICU Medical's Operating Profit Margin is plotted below across several periods. Revenue and margin trends can explain shifts in this metric.

Inputs for ICU Medical come from periodic company reporting and market reference feeds and are mapped into a consistent reporting framework. Some fields can appear with publication lag. This section presents reference data and historical patterns only and does not constitute an investment recommendation or advice.

This content is curated and reviewed by:

Michael Smolkin - Member of Macroaxis Board of Directors
Last reviewed on March 7th, 2026